1. Home
  2. RCKT vs RR Comparison

RCKT vs RR Comparison

Compare RCKT & RR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$2.18

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$1.28

Market Cap

375.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
RR
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.2M
375.9M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
RCKT
RR
Price
$2.18
$1.28
Analyst Decision
Buy
Analyst Count
14
0
Target Price
★ $8.58
N/A
AVG Volume (30 Days)
2.1M
★ 3.9M
Earning Date
11-05-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 26.37
N/A
EPS
★ 0.66
N/A
Revenue
N/A
★ $5,045,000.00
Revenue This Year
N/A
$8.03
Revenue Next Year
$915.60
$22.75
P/E Ratio
$3.58
★ N/A
Revenue Growth
N/A
★ 18.99
52 Week Low
$2.18
$1.30
52 Week High
$5.45
$6.40

Technical Indicators

Market Signals
Indicator
RCKT
RR
Relative Strength Index (RSI) 29.92 30.36
Support Level N/A N/A
Resistance Level $3.70 $1.79
Average True Range (ATR) 0.16 0.09
MACD -0.01 -0.03
Stochastic Oscillator 5.00 2.10

Price Performance

Historical Comparison
RCKT
RR

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

Share on Social Networks: